Retrospective study highlights safety concerns with intravenous immunoglobulin in obstetrics, suggesting need for policy improvements.
Findings highlight the need for optimized intravenous immunoglobulin use in obstetrics and future research to ensure safety, efficacy, and evidence-based guidance in clinical practice and policy.
No takes yet. Share an insight, caveat, or question.
Khalifé et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: